immune response

Arcturus reports positive results for sa-mRNA COVID boosters in phase 1/2 trial

Amid a shrinking COVID-19 vaccine market, Arcturus Therapeutics is forging ahead with its mRNA candidate, revealing promising early data demonstrating ...